Rare diseases
Investigational molecules
Locations
Back to France951 clinical trials in Nantes, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis
FranceStudy on Reducing Chemotherapy for Patients with Low-Risk Localized Gastroesophageal Cancer Using Docetaxel, Oxaliplatin, Calcium Folinate, and Fluorouracil
FranceStudy of Posaconazole for Preventing Fungal Infections in Patients Receiving Stem Cell Transplants for Blood Cancer
FranceStudy on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis
FranceStudy on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma
FranceStudy of ponatinib and azacitidine combination treatment in patients with accelerated phase or blast crisis chronic myelogenous leukemia
FranceStudy on Itacitinib for Adults with Diffuse Systemic Sclerosis
FranceStudy of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma
FranceStudy on L19IL2 and L19TNF Treatment Before Surgery for Patients with Advanced Melanoma
FranceStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
FranceStudy on Dostarlimab, Vitamin D3, and Drug Combination for Untreated Metastatic Pancreatic Cancer Patients
FranceFranceThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on multiple myeloma, leukemia, and various lymphomas. Studies are evaluating novel treatment combinations and therapeutic approaches for blood cancers.
Innovative trials exploring combinations of targeted therapies and immunotherapies to improve patient outcomes.
Comprehensive studies on preventive measures against viral infections, including trials for vaccines targeting CMV, yellow fever, and mpox.
Focus on developing and evaluating new vaccine formulations and delivery methods.
Research investigating treatments for inflammatory bowel diseases and multiple sclerosis, including innovative approaches like fecal microbiota transplantation.
Exploring novel therapeutic options and treatment de-escalation strategies.
Studies addressing postoperative care and management of severe conditions in intensive care settings, including burns and immune suppression.
Evaluating new approaches to improve patient comfort and outcomes in critical care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
